Coronary diseaseInternational Joint Sessions

SOLACI-CACI 2021 | TCT Session: The Future of PCI

solaci
solaci
516
0

✔️ Watch the TCT session in the Congreso SOLACI-CACI 2021.

👨‍🏫 Program:

  • 00:54 – The Future of PCI. Identification and treatment of vulnerable plaque – Gregg Stone
  • 32:50 – State of the Art: Intracoronary Imaging – Gary Mintz
  • 57:04 – DAPT: Today and Beyond – Roxana Mehran

✔️ Chairpersons: Aníbal Damonte & Alfredo E. Rodríguez.
✔️ Digital Moderator: Miguel Larribau.
✔️ Panelistas: Chavarría, Jorge – Feres, Fausto – Fernández, Alejandro Abel – Pérez de la Hoz, Ricardo -Rubilar, Bibiana – Veas, Nicolás.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-CACI 2021 | ProEducar Educational Seminars
Next article
SOLACI-CACI 2021 | EuroPCR Session
solaci
solaci

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Dr. Andrés Rodríguez - 0
Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Dr. Omar Tupayachi - 0
Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Dr. Omar Tupayachi - 0
Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Dr. Juan Manuel Pérez - 0
Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Acute coronary syndromes

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the...
Dr. Andrés Rodríguez -
SOLACI Sessionsspot_img

Recent Articles

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Dr. Juan Manuel Pérez - 0
Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Dr. Andrés Rodríguez - 0
Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...